...
首页> 外文期刊>Journal of Feline Medicine and Surgery Open Reports >Successful treatment of feline leishmaniosis using a combination of allopurinol and N-methyl-glucamine antimoniate
【24h】

Successful treatment of feline leishmaniosis using a combination of allopurinol and N-methyl-glucamine antimoniate

机译:别嘌醇和N-甲基葡萄糖胺锑酸盐的组合成功治疗猫利什曼病

获取原文
           

摘要

This work describes the diagnosis and successful treatment of a 2-year-old domestic cat infected with Leishmania species and presenting fever, and ulcerative and nodular skin lesions after being treated for pyodermatitis for 1 year without clinical improvement. After anamnesis the cat was submitted to a complete clinical examination. Blood was collected for determination of haematological and biochemical parameters, detection of feline leukaemia virus (FeLV), feline immunodeficiency virus (FIV), feline coronavirus (FCoV) and Leishmania amastigotes. Fine-needle aspiration puncture from the skin nodules was also performed. After definitive diagnosis the animal was treated and followed up over a 2 year period. The animal tested negative for FIV-specific antibodies, FeLV antigen and feline coronavirus RNA. Leishmania amastigotes in the skin nodules were confirmed by cytology and molecular diagnosis. Treatment was initiated with allopurinol, resulting in a slight clinical improvement. Thus, N-methyl-glucamine antimoniate was added and administered for 30 days, with complete closure of the ulcerative lesions in the hindlimbs requiring a surgical approach. Close monitoring of the patient in the following 24 months indicated that combined therapy was safe and clinical cure was achieved without further relapses or side effects.
机译:这项工作描述了诊断为2岁的家猫,该猫感染了利什曼原虫种并在治疗脓皮炎1年后出现发烧,溃疡性和结节性皮肤病变,但无临床改善。记忆删除后,猫接受了完整的临床检查。收集血液以确定血液学和生化参数,检测猫白血病病毒(FeLV),猫免疫缺陷病毒(FIV),猫冠状病毒(FCoV)和利什曼原虫。还进行了从皮肤结节的细针穿刺穿刺。明确诊断后,对动物进行治疗,并在2年内进行随访。该动物测试的FIV特异性抗体,FeLV抗原和猫冠状病毒RNA阴性。通过细胞学和分子诊断证实了皮肤结节中的利什曼原虫amastigotes。用别嘌呤醇开始治疗,导致临床略有改善。因此,加入N-甲基-葡糖胺锑酸盐并施用30天,完全封闭后肢中的溃疡性病变,需要手术方法。在接下来的24个月中,对患者进行的密切监测表明,联合治疗是安全的,并且可以实现临床治愈,且无进一步复发或副作用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号